A Phase 1-1b Study to Evaluate the Safety, Efficacy and Dosimetry of Study Drug A9-3408 in Subjects With Metastatic Melanoma
Abroad (travel likely)RecruitingPHASE1
Conditions
Melanoma Metastatic · Uveal Melanoma, Metastatic · Mucosal Melanoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Alfred Health, Melbourne, Victoria, Australia
Contact: Principal Investigator (Dr. Malaka Ameratunga)Austin Health, Melbourne, Victoria, Australia
Contact: Principal Investigator (Prof. Andrew Scott)Fiona Stanley Hospital, Murdoch, Western Australia, Australia
Contact: Principal Investigator (Dr. Zeyad Al-Ogaili)GenesisCare Murdoch, Murdoch, Western Australia, Australia
Contact: Principal Investigator (Prof Joe Cardaci)